Molly Harper
Director/Board Member presso CATALYST PHARMACEUTICALS, INC.
Patrimonio netto: 85 008 $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Richard Daly | M | 62 | 9 anni | |
| Antoine Awad | M | 44 | 6 anni | |
| Patrick McEnany | M | 77 | 22 anni | |
| Mary Dooley | F | 43 | 6 anni | |
| Charles O'Keeffe | M | 84 | 20 anni | |
| Steven Miller | M | 62 | 17 anni | |
| Donald Denkhaus | M | 78 | 9 anni | |
| Brendan St Amant | M | - | 3 anni | |
| Jeff Del Carmen | M | 53 | 6 anni | |
| Gary Ingenito | M | 68 | 9 anni | |
| Thomas J. Adam | M | - | 7 anni | |
| Richard Shea | M | 72 | 7 anni | |
| David Tierney | M | 60 | 22 anni | |
| Brian Elsbernd | M | 60 | 8 anni | |
| Peter Barrett | M | 71 | 7 anni | |
| Nick Leschly | M | 51 | 7 anni | |
| Michael Heffernan | M | 59 | 4 anni | |
| Ed Mathers Mathers | M | 64 | 12 anni | |
| Erik Lium | M | 56 |
PreciseDx Ltd.
 PreciseDx Ltd. Data Processing ServicesTechnology Services PreciseDx Ltd. is a British AI company that specializes in oncology diagnostics. The company is based in Altrincham, UK. The company leverage the analysis of morphology features from histology slides to provide more precise patient-specific risk information. The company's proprietary morphology feature array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making. The company was founded in 2019. Wayne L. Brinster has been the CEO of the company since 2021. | - |
| Preethi Sundaram | M | 47 | 3 anni | |
| Caroline Kurtz | M | - | 8 anni | |
| Tamar Thompson | F | 50 | 1 anni | |
| Pete Curry | M | - | 4 anni | |
| Mary Coleman | F | - | 3 anni | |
| Philip B. Schwartz | M | - | - | |
| Stanley Iyadurai | M | - | 6 anni | |
| Michael Kalb | M | 53 | - | |
| Brad H. Gendell | M | - |
PreciseDx Ltd.
PreciseDx Ltd. Data Processing ServicesTechnology Services PreciseDx Ltd. is a British AI company that specializes in oncology diagnostics. The company is based in Altrincham, UK. The company leverage the analysis of morphology features from histology slides to provide more precise patient-specific risk information. The company's proprietary morphology feature array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making. The company was founded in 2019. Wayne L. Brinster has been the CEO of the company since 2021. | 2 anni |
| Paul J. Roma | M | - |
PreciseDx Ltd.
PreciseDx Ltd. Data Processing ServicesTechnology Services PreciseDx Ltd. is a British AI company that specializes in oncology diagnostics. The company is based in Altrincham, UK. The company leverage the analysis of morphology features from histology slides to provide more precise patient-specific risk information. The company's proprietary morphology feature array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making. The company was founded in 2019. Wayne L. Brinster has been the CEO of the company since 2021. | 1 anni |
| Eric Converse | M | 56 |
PreciseDx Ltd.
PreciseDx Ltd. Data Processing ServicesTechnology Services PreciseDx Ltd. is a British AI company that specializes in oncology diagnostics. The company is based in Altrincham, UK. The company leverage the analysis of morphology features from histology slides to provide more precise patient-specific risk information. The company's proprietary morphology feature array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making. The company was founded in 2019. Wayne L. Brinster has been the CEO of the company since 2021. | 2 anni |
| Wayne L. Brinster | M | - |
PreciseDx Ltd.
PreciseDx Ltd. Data Processing ServicesTechnology Services PreciseDx Ltd. is a British AI company that specializes in oncology diagnostics. The company is based in Altrincham, UK. The company leverage the analysis of morphology features from histology slides to provide more precise patient-specific risk information. The company's proprietary morphology feature array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making. The company was founded in 2019. Wayne L. Brinster has been the CEO of the company since 2021. | 3 anni |
| Maria Pandolfo | F | - | 6 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Aoife Brennan | M | 48 | 8 anni | |
| Alicia Grande | F | 53 | 16 anni | |
| Philip Coelho | M | 80 | 21 anni | |
| Lisa Kelly-Croswell | F | 57 | 3 anni | |
| Michael Burgess | M | 61 | 4 anni | |
| Patricia Hurter | M | 60 | 5 anni | |
| Gregg Beloff | M | 56 | 3 anni | |
| David L. Hava | M | 49 | 3 anni | |
| David Ailinger | M | - | 2 anni | |
| Daniel Rosan | M | - | 1 anni | |
| Jamie Austin | M | - | - | |
| Michael Jensen | M | 48 | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 39 | 88.64% |
| Regno Unito | 5 | 11.36% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Molly Harper
- Contatti personali
